Hill-Kapturczak Nathalie, Sikorski Eric, Voakes Christy, Garcia Jairo, Nick Harry S, Agarwal Anupam
Department of Medicine, Div. of Nephrology, Hypertension, and Transplantation, Univ. of Florida, Gainesville, FL 32610, USA.
Am J Physiol Renal Physiol. 2003 Sep;285(3):F515-23. doi: 10.1152/ajprenal.00137.2003. Epub 2003 Jun 3.
Heme oxygenase-1 (HO-1) catalyzes the rate-limiting step in heme degradation, releasing iron, carbon monoxide, and biliverdin. Induction of HO-1 is an adaptive and beneficial response in renal and nonrenal settings of tissue injury. The purpose of this study was to characterize the regulation of the human HO-1 gene in renal proximal tubule and aortic endothelial cells in response to heme and cadmium. Evaluation of multiple human HO-1 promoter-reporter constructs up to -9.1 kb demonstrated only a partial response to heme and cadmium. In an effort to mimic endogenous stimulus-dependent levels of HO-1 induction, we evaluated the entire 12.5 kb of the human HO-1 gene, including introns and exons, in conjunction with a -4.5-kb human HO-1 promoter and observed significant heme- and cadmium-mediated induction of the reporter gene, suggesting the presence of an internal enhancer. Enhancer function was orientation independent and required a region between -3.5 and -4.5 kb of the human HO-1 promoter. Our studies identified a novel enhancer internal to the human HO-1 gene that, in conjunction with the HO-1 promoter, recapitulates heme- and cadmium-mediated induction of the endogenous HO-1 gene. Elucidation of the molecular regulation of the human HO-1 gene will allow for the development of therapeutic strategies to manipulate HO-1 gene expression in pathological states.
血红素加氧酶-1(HO-1)催化血红素降解的限速步骤,释放铁、一氧化碳和胆绿素。在肾脏和非肾脏组织损伤的情况下,诱导HO-1是一种适应性的有益反应。本研究的目的是描述人HO-1基因在肾近端小管和主动脉内皮细胞中对血红素和镉的反应调节。对长达-9.1 kb的多种人HO-1启动子-报告基因构建体的评估仅显示对血红素和镉的部分反应。为了模拟内源性刺激依赖的HO-1诱导水平,我们评估了人HO-1基因的整个12.5 kb,包括内含子和外显子,并结合一个-4.5 kb的人HO-1启动子,观察到报告基因有显著的血红素和镉介导的诱导,提示存在一个内部增强子。增强子功能不依赖方向,需要人HO-1启动子-3.5至-4.5 kb之间的区域。我们的研究确定了人HO-1基因内部的一个新型增强子,该增强子与HO-1启动子一起,概括了血红素和镉介导的内源性HO-1基因诱导。阐明人HO-1基因的分子调节将有助于开发在病理状态下操纵HO-1基因表达的治疗策略。